What is the current valuation of the Molluscicides Market as of 2024?

The Molluscicides Market was valued at 812.5 USD Million in 2024. Read More

What is the projected market valuation for the Molluscicides Market in 2035?

The market is projected to reach 1466.02 USD Million by 2035. Read More

What is the expected CAGR for the Molluscicides Market during the forecast period 2025 - 2035?

The expected CAGR for the Molluscicides Market during 2025 - 2035 is 5.47%. Read More

Which companies are considered key players in the Molluscicides Market?

Key players in the market include BASF SE, Bayer AG, Syngenta AG, FMC Corporation, and others. Read More

What are the primary applications of molluscicides in the market?

The primary applications include Agriculture, Horticulture, Aquaculture, and Public Health, with Agriculture valued at 300.0 to 550.0 USD Million. Read More

How is the Molluscicides Market segmented by formulation type?

The market is segmented into Granular, Liquid, Pellet, and Emulsifiable Concentrate, with Liquid valued at 325.0 to 590.0 USD Million. Read More

What target organisms are primarily addressed by molluscicides?

The primary target organisms include Snails, Slugs, and Other Gastropods, with Snails valued at 300.0 to 550.0 USD Million. Read More

What modes of action are utilized by molluscicides in the market?

Molluscicides operate through Contact, Ingestion, and Systemic modes, with Ingestion valued at 325.0 to 590.0 USD Million. Read More

What is the regulatory status of molluscicides in the market?

The regulatory status includes Registered, Pending Approval, and Banned, with Registered products valued at 500.0 to 900.0 USD Million. Read More

How does the market performance of molluscicides in 2024 compare to projections for 2035?

The market performance in 2024 at 812.5 USD Million is expected to grow to 1466.02 USD Million by 2035. Read More

Molluscicides Market

ID: MRFR/Agri/3813-HCR

110 Pages

Snehal Singh

Last Updated: April 06, 2026

Molluscicides Market Size, Share, Industry Trend & Analysis Research Report Information By Type (Chemical Metaldehyde, Methiocarb, Ferric Phosphate, Biological, and Others), By Form (Dry and Liquid), By Crop Type (Vegetables & Fruits, Cereals & Grains, Oilseeds & Pulses, Ornaments and Turf, and Others), and By Region (North America, Europe, Asia-Pacific, and Rest Of The World) – Forecast Till 2035

Molluscicides Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)5.47%

2024 Market Size$ 812.5 Million

2025 Market Size$ 866.26 Million

2035 Market Size$ 1,466.02 Million

Key Players

BASF SE

Bayer AG

Syngenta AG

FMC Corporation

ADAMA Agricultural Solutions Ltd.

Nufarm Limited

Trends

No data available

Opportunities

Market Growth Projections
Regulatory Support for Biopesticides
Rising Demand for Sustainable Agriculture

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Healthcare, BY Application (USD Million)
  1. 4.1.1 Agriculture
  2. 4.1.2 Horticulture
  3. 4.1.3 Aquaculture
  4. 4.1.4 Public Health
2. 4.2 Healthcare, BY Formulation Type (USD Million)
  1. 4.2.1 Granular
  2. 4.2.2 Liquid
  3. 4.2.3 Pellet
  4. 4.2.4 Emulsifiable Concentrate
3. 4.3 Healthcare, BY Target Organism (USD Million)
  1. 4.3.1 Snails
  2. 4.3.2 Slugs
  3. 4.3.3 Other Gastropods
4. 4.4 Healthcare, BY Mode of Action (USD Million)
  1. 4.4.1 Contact
  2. 4.4.2 Ingestion
  3. 4.4.3 Systemic
5. 4.5 Healthcare, BY Regulatory Status (USD Million)
  1. 4.5.1 Registered
  2. 4.5.2 Pending Approval
  3. 4.5.3 Banned
6. 4.6 Healthcare, BY Region (USD Million)
  1. 4.6.1 North America
    1. 4.6.1.1 US
    2. 4.6.1.2 Canada
  2. 4.6.2 Europe
    1. 4.6.2.1 Germany
    2. 4.6.2.2 UK
    3. 4.6.2.3 France
    4. 4.6.2.4 Russia
    5. 4.6.2.5 Italy
    6. 4.6.2.6 Spain
    7. 4.6.2.7 Rest of Europe
  3. 4.6.3 APAC
    1. 4.6.3.1 China
    2. 4.6.3.2 India
    3. 4.6.3.3 Japan
    4. 4.6.3.4 South Korea
    5. 4.6.3.5 Malaysia
    6. 4.6.3.6 Thailand
    7. 4.6.3.7 Indonesia
    8. 4.6.3.8 Rest of APAC
  4. 4.6.4 South America
    1. 4.6.4.1 Brazil
    2. 4.6.4.2 Mexico
    3. 4.6.4.3 Argentina
    4. 4.6.4.4 Rest of South America
  5. 4.6.5 MEA
    1. 4.6.5.1 GCC Countries
    2. 4.6.5.2 South Africa
    3. 4.6.5.3 Rest of MEA
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Healthcare
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 BASF SE (DE)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Bayer AG (DE)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Syngenta AG (CH)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 FMC Corporation (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 ADAMA Agricultural Solutions Ltd. (IL)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Nufarm Limited (AU)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Sumitomo Chemical Co., Ltd. (JP)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 UPL Limited (IN)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Isagro S.p.A. (IT)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 NORTH AMERICA MARKET ANALYSIS
3. 6.3 US MARKET ANALYSIS BY APPLICATION
4. 6.4 US MARKET ANALYSIS BY FORMULATION TYPE
5. 6.5 US MARKET ANALYSIS BY TARGET ORGANISM
6. 6.6 US MARKET ANALYSIS BY MODE OF ACTION
7. 6.7 US MARKET ANALYSIS BY REGULATORY STATUS
8. 6.8 CANADA MARKET ANALYSIS BY APPLICATION
9. 6.9 CANADA MARKET ANALYSIS BY FORMULATION TYPE
10. 6.10 CANADA MARKET ANALYSIS BY TARGET ORGANISM
11. 6.11 CANADA MARKET ANALYSIS BY MODE OF ACTION
12. 6.12 CANADA MARKET ANALYSIS BY REGULATORY STATUS
13. 6.13 EUROPE MARKET ANALYSIS
14. 6.14 GERMANY MARKET ANALYSIS BY APPLICATION
15. 6.15 GERMANY MARKET ANALYSIS BY FORMULATION TYPE
16. 6.16 GERMANY MARKET ANALYSIS BY TARGET ORGANISM
17. 6.17 GERMANY MARKET ANALYSIS BY MODE OF ACTION
18. 6.18 GERMANY MARKET ANALYSIS BY REGULATORY STATUS
19. 6.19 UK MARKET ANALYSIS BY APPLICATION
20. 6.20 UK MARKET ANALYSIS BY FORMULATION TYPE
21. 6.21 UK MARKET ANALYSIS BY TARGET ORGANISM
22. 6.22 UK MARKET ANALYSIS BY MODE OF ACTION
23. 6.23 UK MARKET ANALYSIS BY REGULATORY STATUS
24. 6.24 FRANCE MARKET ANALYSIS BY APPLICATION
25. 6.25 FRANCE MARKET ANALYSIS BY FORMULATION TYPE
26. 6.26 FRANCE MARKET ANALYSIS BY TARGET ORGANISM
27. 6.27 FRANCE MARKET ANALYSIS BY MODE OF ACTION
28. 6.28 FRANCE MARKET ANALYSIS BY REGULATORY STATUS
29. 6.29 RUSSIA MARKET ANALYSIS BY APPLICATION
30. 6.30 RUSSIA MARKET ANALYSIS BY FORMULATION TYPE
31. 6.31 RUSSIA MARKET ANALYSIS BY TARGET ORGANISM
32. 6.32 RUSSIA MARKET ANALYSIS BY MODE OF ACTION
33. 6.33 RUSSIA MARKET ANALYSIS BY REGULATORY STATUS
34. 6.34 ITALY MARKET ANALYSIS BY APPLICATION
35. 6.35 ITALY MARKET ANALYSIS BY FORMULATION TYPE
36. 6.36 ITALY MARKET ANALYSIS BY TARGET ORGANISM
37. 6.37 ITALY MARKET ANALYSIS BY MODE OF ACTION
38. 6.38 ITALY MARKET ANALYSIS BY REGULATORY STATUS
39. 6.39 SPAIN MARKET ANALYSIS BY APPLICATION
40. 6.40 SPAIN MARKET ANALYSIS BY FORMULATION TYPE
41. 6.41 SPAIN MARKET ANALYSIS BY TARGET ORGANISM
42. 6.42 SPAIN MARKET ANALYSIS BY MODE OF ACTION
43. 6.43 SPAIN MARKET ANALYSIS BY REGULATORY STATUS
44. 6.44 REST OF EUROPE MARKET ANALYSIS BY APPLICATION
45. 6.45 REST OF EUROPE MARKET ANALYSIS BY FORMULATION TYPE
46. 6.46 REST OF EUROPE MARKET ANALYSIS BY TARGET ORGANISM
47. 6.47 REST OF EUROPE MARKET ANALYSIS BY MODE OF ACTION
48. 6.48 REST OF EUROPE MARKET ANALYSIS BY REGULATORY STATUS
49. 6.49 APAC MARKET ANALYSIS
50. 6.50 CHINA MARKET ANALYSIS BY APPLICATION
51. 6.51 CHINA MARKET ANALYSIS BY FORMULATION TYPE
52. 6.52 CHINA MARKET ANALYSIS BY TARGET ORGANISM
53. 6.53 CHINA MARKET ANALYSIS BY MODE OF ACTION
54. 6.54 CHINA MARKET ANALYSIS BY REGULATORY STATUS
55. 6.55 INDIA MARKET ANALYSIS BY APPLICATION
56. 6.56 INDIA MARKET ANALYSIS BY FORMULATION TYPE
57. 6.57 INDIA MARKET ANALYSIS BY TARGET ORGANISM
58. 6.58 INDIA MARKET ANALYSIS BY MODE OF ACTION
59. 6.59 INDIA MARKET ANALYSIS BY REGULATORY STATUS
60. 6.60 JAPAN MARKET ANALYSIS BY APPLICATION
61. 6.61 JAPAN MARKET ANALYSIS BY FORMULATION TYPE
62. 6.62 JAPAN MARKET ANALYSIS BY TARGET ORGANISM
63. 6.63 JAPAN MARKET ANALYSIS BY MODE OF ACTION
64. 6.64 JAPAN MARKET ANALYSIS BY REGULATORY STATUS
65. 6.65 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
66. 6.66 SOUTH KOREA MARKET ANALYSIS BY FORMULATION TYPE
67. 6.67 SOUTH KOREA MARKET ANALYSIS BY TARGET ORGANISM
68. 6.68 SOUTH KOREA MARKET ANALYSIS BY MODE OF ACTION
69. 6.69 SOUTH KOREA MARKET ANALYSIS BY REGULATORY STATUS
70. 6.70 MALAYSIA MARKET ANALYSIS BY APPLICATION
71. 6.71 MALAYSIA MARKET ANALYSIS BY FORMULATION TYPE
72. 6.72 MALAYSIA MARKET ANALYSIS BY TARGET ORGANISM
73. 6.73 MALAYSIA MARKET ANALYSIS BY MODE OF ACTION
74. 6.74 MALAYSIA MARKET ANALYSIS BY REGULATORY STATUS
75. 6.75 THAILAND MARKET ANALYSIS BY APPLICATION
76. 6.76 THAILAND MARKET ANALYSIS BY FORMULATION TYPE
77. 6.77 THAILAND MARKET ANALYSIS BY TARGET ORGANISM
78. 6.78 THAILAND MARKET ANALYSIS BY MODE OF ACTION
79. 6.79 THAILAND MARKET ANALYSIS BY REGULATORY STATUS
80. 6.80 INDONESIA MARKET ANALYSIS BY APPLICATION
81. 6.81 INDONESIA MARKET ANALYSIS BY FORMULATION TYPE
82. 6.82 INDONESIA MARKET ANALYSIS BY TARGET ORGANISM
83. 6.83 INDONESIA MARKET ANALYSIS BY MODE OF ACTION
84. 6.84 INDONESIA MARKET ANALYSIS BY REGULATORY STATUS
85. 6.85 REST OF APAC MARKET ANALYSIS BY APPLICATION
86. 6.86 REST OF APAC MARKET ANALYSIS BY FORMULATION TYPE
87. 6.87 REST OF APAC MARKET ANALYSIS BY TARGET ORGANISM
88. 6.88 REST OF APAC MARKET ANALYSIS BY MODE OF ACTION
89. 6.89 REST OF APAC MARKET ANALYSIS BY REGULATORY STATUS
90. 6.90 SOUTH AMERICA MARKET ANALYSIS
91. 6.91 BRAZIL MARKET ANALYSIS BY APPLICATION
92. 6.92 BRAZIL MARKET ANALYSIS BY FORMULATION TYPE
93. 6.93 BRAZIL MARKET ANALYSIS BY TARGET ORGANISM
94. 6.94 BRAZIL MARKET ANALYSIS BY MODE OF ACTION
95. 6.95 BRAZIL MARKET ANALYSIS BY REGULATORY STATUS
96. 6.96 MEXICO MARKET ANALYSIS BY APPLICATION
97. 6.97 MEXICO MARKET ANALYSIS BY FORMULATION TYPE
98. 6.98 MEXICO MARKET ANALYSIS BY TARGET ORGANISM
99. 6.99 MEXICO MARKET ANALYSIS BY MODE OF ACTION
100. 6.100 MEXICO MARKET ANALYSIS BY REGULATORY STATUS
101. 6.101 ARGENTINA MARKET ANALYSIS BY APPLICATION
102. 6.102 ARGENTINA MARKET ANALYSIS BY FORMULATION TYPE
103. 6.103 ARGENTINA MARKET ANALYSIS BY TARGET ORGANISM
104. 6.104 ARGENTINA MARKET ANALYSIS BY MODE OF ACTION
105. 6.105 ARGENTINA MARKET ANALYSIS BY REGULATORY STATUS
106. 6.106 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
107. 6.107 REST OF SOUTH AMERICA MARKET ANALYSIS BY FORMULATION TYPE
108. 6.108 REST OF SOUTH AMERICA MARKET ANALYSIS BY TARGET ORGANISM
109. 6.109 REST OF SOUTH AMERICA MARKET ANALYSIS BY MODE OF ACTION
110. 6.110 REST OF SOUTH AMERICA MARKET ANALYSIS BY REGULATORY STATUS
111. 6.111 MEA MARKET ANALYSIS
112. 6.112 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION
113. 6.113 GCC COUNTRIES MARKET ANALYSIS BY FORMULATION TYPE
114. 6.114 GCC COUNTRIES MARKET ANALYSIS BY TARGET ORGANISM
115. 6.115 GCC COUNTRIES MARKET ANALYSIS BY MODE OF ACTION
116. 6.116 GCC COUNTRIES MARKET ANALYSIS BY REGULATORY STATUS
117. 6.117 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION
118. 6.118 SOUTH AFRICA MARKET ANALYSIS BY FORMULATION TYPE
119. 6.119 SOUTH AFRICA MARKET ANALYSIS BY TARGET ORGANISM
120. 6.120 SOUTH AFRICA MARKET ANALYSIS BY MODE OF ACTION
121. 6.121 SOUTH AFRICA MARKET ANALYSIS BY REGULATORY STATUS
122. 6.122 REST OF MEA MARKET ANALYSIS BY APPLICATION
123. 6.123 REST OF MEA MARKET ANALYSIS BY FORMULATION TYPE
124. 6.124 REST OF MEA MARKET ANALYSIS BY TARGET ORGANISM
125. 6.125 REST OF MEA MARKET ANALYSIS BY MODE OF ACTION
126. 6.126 REST OF MEA MARKET ANALYSIS BY REGULATORY STATUS
127. 6.127 KEY BUYING CRITERIA OF HEALTHCARE
128. 6.128 RESEARCH PROCESS OF MRFR
129. 6.129 DRO ANALYSIS OF HEALTHCARE
130. 6.130 DRIVERS IMPACT ANALYSIS: HEALTHCARE
131. 6.131 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
132. 6.132 SUPPLY / VALUE CHAIN: HEALTHCARE
133. 6.133 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
134. 6.134 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Million)
135. 6.135 HEALTHCARE, BY FORMULATION TYPE, 2024 (% SHARE)
136. 6.136 HEALTHCARE, BY FORMULATION TYPE, 2024 TO 2035 (USD Million)
137. 6.137 HEALTHCARE, BY TARGET ORGANISM, 2024 (% SHARE)
138. 6.138 HEALTHCARE, BY TARGET ORGANISM, 2024 TO 2035 (USD Million)
139. 6.139 HEALTHCARE, BY MODE OF ACTION, 2024 (% SHARE)
140. 6.140 HEALTHCARE, BY MODE OF ACTION, 2024 TO 2035 (USD Million)
141. 6.141 HEALTHCARE, BY REGULATORY STATUS, 2024 (% SHARE)
142. 6.142 HEALTHCARE, BY REGULATORY STATUS, 2024 TO 2035 (USD Million)
143. 6.143 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 North America MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.2.2 BY FORMULATION TYPE, 2025-2035 (USD Million)
  3. 7.2.3 BY TARGET ORGANISM, 2025-2035 (USD Million)
  4. 7.2.4 BY MODE OF ACTION, 2025-2035 (USD Million)
  5. 7.2.5 BY REGULATORY STATUS, 2025-2035 (USD Million)
2. 7.3 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.3.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.3.2 BY FORMULATION TYPE, 2025-2035 (USD Million)
  3. 7.3.3 BY TARGET ORGANISM, 2025-2035 (USD Million)
  4. 7.3.4 BY MODE OF ACTION, 2025-2035 (USD Million)
  5. 7.3.5 BY REGULATORY STATUS, 2025-2035 (USD Million)
3. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  1. 7.4.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.4.2 BY FORMULATION TYPE, 2025-2035 (USD Million)
  3. 7.4.3 BY TARGET ORGANISM, 2025-2035 (USD Million)
  4. 7.4.4 BY MODE OF ACTION, 2025-2035 (USD Million)
  5. 7.4.5 BY REGULATORY STATUS, 2025-2035 (USD Million)
4. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.5.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.5.2 BY FORMULATION TYPE, 2025-2035 (USD Million)
  3. 7.5.3 BY TARGET ORGANISM, 2025-2035 (USD Million)
  4. 7.5.4 BY MODE OF ACTION, 2025-2035 (USD Million)
  5. 7.5.5 BY REGULATORY STATUS, 2025-2035 (USD Million)
5. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  1. 7.6.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.6.2 BY FORMULATION TYPE, 2025-2035 (USD Million)
  3. 7.6.3 BY TARGET ORGANISM, 2025-2035 (USD Million)
  4. 7.6.4 BY MODE OF ACTION, 2025-2035 (USD Million)
  5. 7.6.5 BY REGULATORY STATUS, 2025-2035 (USD Million)
6. 7.7 UK MARKET SIZE ESTIMATES; FORECAST
  1. 7.7.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.7.2 BY FORMULATION TYPE, 2025-2035 (USD Million)
  3. 7.7.3 BY TARGET ORGANISM, 2025-2035 (USD Million)
  4. 7.7.4 BY MODE OF ACTION, 2025-2035 (USD Million)
  5. 7.7.5 BY REGULATORY STATUS, 2025-2035 (USD Million)
7. 7.8 France MARKET SIZE ESTIMATES; FORECAST
  1. 7.8.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.8.2 BY FORMULATION TYPE, 2025-2035 (USD Million)
  3. 7.8.3 BY TARGET ORGANISM, 2025-2035 (USD Million)
  4. 7.8.4 BY MODE OF ACTION, 2025-2035 (USD Million)
  5. 7.8.5 BY REGULATORY STATUS, 2025-2035 (USD Million)
8. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  1. 7.9.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.9.2 BY FORMULATION TYPE, 2025-2035 (USD Million)
  3. 7.9.3 BY TARGET ORGANISM, 2025-2035 (USD Million)
  4. 7.9.4 BY MODE OF ACTION, 2025-2035 (USD Million)
  5. 7.9.5 BY REGULATORY STATUS, 2025-2035 (USD Million)
9. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  1. 7.10.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.10.2 BY FORMULATION TYPE, 2025-2035 (USD Million)
  3. 7.10.3 BY TARGET ORGANISM, 2025-2035 (USD Million)
  4. 7.10.4 BY MODE OF ACTION, 2025-2035 (USD Million)
  5. 7.10.5 BY REGULATORY STATUS, 2025-2035 (USD Million)
10. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  1. 7.11.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.11.2 BY FORMULATION TYPE, 2025-2035 (USD Million)
  3. 7.11.3 BY TARGET ORGANISM, 2025-2035 (USD Million)
  4. 7.11.4 BY MODE OF ACTION, 2025-2035 (USD Million)
  5. 7.11.5 BY REGULATORY STATUS, 2025-2035 (USD Million)
11. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.12.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.12.2 BY FORMULATION TYPE, 2025-2035 (USD Million)
  3. 7.12.3 BY TARGET ORGANISM, 2025-2035 (USD Million)
  4. 7.12.4 BY MODE OF ACTION, 2025-2035 (USD Million)
  5. 7.12.5 BY REGULATORY STATUS, 2025-2035 (USD Million)
12. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.13.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.13.2 BY FORMULATION TYPE, 2025-2035 (USD Million)
  3. 7.13.3 BY TARGET ORGANISM, 2025-2035 (USD Million)
  4. 7.13.4 BY MODE OF ACTION, 2025-2035 (USD Million)
  5. 7.13.5 BY REGULATORY STATUS, 2025-2035 (USD Million)
13. 7.14 China MARKET SIZE ESTIMATES; FORECAST
  1. 7.14.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.14.2 BY FORMULATION TYPE, 2025-2035 (USD Million)
  3. 7.14.3 BY TARGET ORGANISM, 2025-2035 (USD Million)
  4. 7.14.4 BY MODE OF ACTION, 2025-2035 (USD Million)
  5. 7.14.5 BY REGULATORY STATUS, 2025-2035 (USD Million)
14. 7.15 India MARKET SIZE ESTIMATES; FORECAST
  1. 7.15.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.15.2 BY FORMULATION TYPE, 2025-2035 (USD Million)
  3. 7.15.3 BY TARGET ORGANISM, 2025-2035 (USD Million)
  4. 7.15.4 BY MODE OF ACTION, 2025-2035 (USD Million)
  5. 7.15.5 BY REGULATORY STATUS, 2025-2035 (USD Million)
15. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  1. 7.16.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.16.2 BY FORMULATION TYPE, 2025-2035 (USD Million)
  3. 7.16.3 BY TARGET ORGANISM, 2025-2035 (USD Million)
  4. 7.16.4 BY MODE OF ACTION, 2025-2035 (USD Million)
  5. 7.16.5 BY REGULATORY STATUS, 2025-2035 (USD Million)
16. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  1. 7.17.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.17.2 BY FORMULATION TYPE, 2025-2035 (USD Million)
  3. 7.17.3 BY TARGET ORGANISM, 2025-2035 (USD Million)
  4. 7.17.4 BY MODE OF ACTION, 2025-2035 (USD Million)
  5. 7.17.5 BY REGULATORY STATUS, 2025-2035 (USD Million)
17. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  1. 7.18.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.18.2 BY FORMULATION TYPE, 2025-2035 (USD Million)
  3. 7.18.3 BY TARGET ORGANISM, 2025-2035 (USD Million)
  4. 7.18.4 BY MODE OF ACTION, 2025-2035 (USD Million)
  5. 7.18.5 BY REGULATORY STATUS, 2025-2035 (USD Million)
18. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  1. 7.19.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.19.2 BY FORMULATION TYPE, 2025-2035 (USD Million)
  3. 7.19.3 BY TARGET ORGANISM, 2025-2035 (USD Million)
  4. 7.19.4 BY MODE OF ACTION, 2025-2035 (USD Million)
  5. 7.19.5 BY REGULATORY STATUS, 2025-2035 (USD Million)
19. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  1. 7.20.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.20.2 BY FORMULATION TYPE, 2025-2035 (USD Million)
  3. 7.20.3 BY TARGET ORGANISM, 2025-2035 (USD Million)
  4. 7.20.4 BY MODE OF ACTION, 2025-2035 (USD Million)
  5. 7.20.5 BY REGULATORY STATUS, 2025-2035 (USD Million)
20. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.21.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.21.2 BY FORMULATION TYPE, 2025-2035 (USD Million)
  3. 7.21.3 BY TARGET ORGANISM, 2025-2035 (USD Million)
  4. 7.21.4 BY MODE OF ACTION, 2025-2035 (USD Million)
  5. 7.21.5 BY REGULATORY STATUS, 2025-2035 (USD Million)
21. 7.22 South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.22.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.22.2 BY FORMULATION TYPE, 2025-2035 (USD Million)
  3. 7.22.3 BY TARGET ORGANISM, 2025-2035 (USD Million)
  4. 7.22.4 BY MODE OF ACTION, 2025-2035 (USD Million)
  5. 7.22.5 BY REGULATORY STATUS, 2025-2035 (USD Million)
22. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  1. 7.23.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.23.2 BY FORMULATION TYPE, 2025-2035 (USD Million)
  3. 7.23.3 BY TARGET ORGANISM, 2025-2035 (USD Million)
  4. 7.23.4 BY MODE OF ACTION, 2025-2035 (USD Million)
  5. 7.23.5 BY REGULATORY STATUS, 2025-2035 (USD Million)
23. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  1. 7.24.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.24.2 BY FORMULATION TYPE, 2025-2035 (USD Million)
  3. 7.24.3 BY TARGET ORGANISM, 2025-2035 (USD Million)
  4. 7.24.4 BY MODE OF ACTION, 2025-2035 (USD Million)
  5. 7.24.5 BY REGULATORY STATUS, 2025-2035 (USD Million)
24. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  1. 7.25.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.25.2 BY FORMULATION TYPE, 2025-2035 (USD Million)
  3. 7.25.3 BY TARGET ORGANISM, 2025-2035 (USD Million)
  4. 7.25.4 BY MODE OF ACTION, 2025-2035 (USD Million)
  5. 7.25.5 BY REGULATORY STATUS, 2025-2035 (USD Million)
25. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.26.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.26.2 BY FORMULATION TYPE, 2025-2035 (USD Million)
  3. 7.26.3 BY TARGET ORGANISM, 2025-2035 (USD Million)
  4. 7.26.4 BY MODE OF ACTION, 2025-2035 (USD Million)
  5. 7.26.5 BY REGULATORY STATUS, 2025-2035 (USD Million)
26. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.27.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.27.2 BY FORMULATION TYPE, 2025-2035 (USD Million)
  3. 7.27.3 BY TARGET ORGANISM, 2025-2035 (USD Million)
  4. 7.27.4 BY MODE OF ACTION, 2025-2035 (USD Million)
  5. 7.27.5 BY REGULATORY STATUS, 2025-2035 (USD Million)
27. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  1. 7.28.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.28.2 BY FORMULATION TYPE, 2025-2035 (USD Million)
  3. 7.28.3 BY TARGET ORGANISM, 2025-2035 (USD Million)
  4. 7.28.4 BY MODE OF ACTION, 2025-2035 (USD Million)
  5. 7.28.5 BY REGULATORY STATUS, 2025-2035 (USD Million)
28. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  1. 7.29.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.29.2 BY FORMULATION TYPE, 2025-2035 (USD Million)
  3. 7.29.3 BY TARGET ORGANISM, 2025-2035 (USD Million)
  4. 7.29.4 BY MODE OF ACTION, 2025-2035 (USD Million)
  5. 7.29.5 BY REGULATORY STATUS, 2025-2035 (USD Million)
29. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.30.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.30.2 BY FORMULATION TYPE, 2025-2035 (USD Million)
  3. 7.30.3 BY TARGET ORGANISM, 2025-2035 (USD Million)
  4. 7.30.4 BY MODE OF ACTION, 2025-2035 (USD Million)
  5. 7.30.5 BY REGULATORY STATUS, 2025-2035 (USD Million)
30. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.31.1
1. 7.32 ACQUISITION/PARTNERSHIP
7.32.1

Certified Researchers

Customize Report

Healthcare Market Segmentation

Healthcare By Application (USD Million, 2025-2035)

Molluscicides Market
Horticulture
Aquaculture
Public Health

Healthcare By Formulation Type (USD Million, 2025-2035)

Granular
Liquid
Pellet
Emulsifiable Concentrate

Healthcare By Target Organism (USD Million, 2025-2035)

Snails
Slugs
Other Gastropods

Healthcare By Mode of Action (USD Million, 2025-2035)

Contact
Ingestion
Systemic

Healthcare By Regulatory Status (USD Million, 2025-2035)

Registered
Pending Approval
Banned

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”